Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129216) titled 'Prospective, multicenter, single-arm study of toripalimab intravesical instillation for high-risk non-muscular invasive urothelial carcinoma of the bladder after bacillus calmette-guerin (BCG) treatment failure' on Aug. 1.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Xinjiang Medical University
Condition:
Malignant bladder tumor
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Experimental group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj...